Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Vomiting × Duration of Therapy × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 1 Osteoarthritis 1 Nausea 1 Cancer Pain 1 Breast Neoplasms 1 Adenomatous Polyposis Coli 1

Interventions

Aprepitant 8 Palonosetron 5 Dexamethasone 5 Granisetron 3 fosaprepitant 2 dexamethasone 21-phosphate 2 Tropisetron 2 Ondansetron 2 Metoclopramide 2 Calcium Dobesilate 2 ramosetron 1 naldemedine 1 dolasetron 1 dexamethasone acetate 1 alizapride 1 Tablets 1 Saline Solution 1 Olanzapine 1 Duration of Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00092183 2017-05-05

An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)

Merck Sharp & Dohme LLC

Phase 4 Completed

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡